HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aloette

This article was originally published in The Rose Sheet

Executive Summary

Enters into an agreement to merge with ACI Acquisition Partners (Marietta, Ga.), the direct marketer, distributor and franchiser said. Under the agreement, ACIA will acquire all outstanding Aloette capital stock for $5.25 a share in cash for an aggregate consideration of about $11.8 mil. to Aloette's shareholders, option and warrant holders. ACIA also will assume roughly $2 mil. in Aloette debt. The purchase is subject to shareholder approval at Aloette's annual meeting, which is slated to be held before the end of July. Aloette sales in 1997 fell 13.7% to $10 mil., while net income declined 19.8% to $738,000. The firm has been working to reduce administrative expenses, which contributed to a 1.9% gain to $265,000 in the fourth quarter, while sales dropped 10.4% to $2.6 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005325

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel